Oncorus, Inc. announced beginning on July 26, 2023, in furtherance of the plan of liquidation and dissolution (the Plan of Dissolution) of the company, each of the company?s six then-serving directors submitted his or her resignation from the board of directors (the board) and the committees thereof. The date on which each director provided notice to the company of his or her intent to resign from the Board and the committees on which he or she served is indicated alongside their names: Theodore (Ted) Ashburn, M.D., Ph.D., July 27, 2023; Mitchell Finer, Ph.D., July 28, 2023; Mary Kay Fenton (Audit Committee, Compensation Committee), July 27, 2023; Spencer Nam (Nominating and Corporate Governance Committee, Audit Committee), July 27, 2023; Eric Rubin, M.D. (Nominating and Corporate Governance Committee), July 26, 2023; Barbara Yanni (Audit Committee), July 26, 2023. Each resignation was effective as of July 28, 2023 upon the adjournment of the special meeting of stockholders.

On July 27, 2023, the Board appointed Craig Jalbert to be the sole member of the Board, with such appointment to be effective concurrently with the effective time of the six director resignations described above. Mr. Jalbert will serve until his successor is duly elected and qualified or until his earlier death, resignation or removal. Effective upon the appointment of Mr. Jalbert, the board also decreased the authorized number of directors from eight (8) to three (3), the minimum required under the company's amended and restated certificate of incorporation (the Certificate of Incorporation).

Mr. Jalbert has not been appointed to any committee of the Board and, as of the date hereof, is not expected to be appointed to any committee of the Board. Mr. Jalbert, age 61, has served as a principal of the Foxborough, Massachusetts-based accounting firm of Verdolino & Lowey, P.C. since 1987. For over 30 years he has focused his practice in distressed businesses and has served, and continues to serve, in the capacities of officer and director for numerous firms in their wind-down phases.

Mr. Jalbert will be compensated in the amount of $50,000 per year for a period of three years. There is no arrangement or understanding pursuant to which Mr. Jalbert was appointed to the Board. There are no family relationships between Mr. Jalbert and any director or executive officer of the Company, and Mr. Jalbert has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.